Clinical Trial: Study of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts.

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524140) titled 'Study of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts.' on March 27.

Brief Summary: Phase 1 Study of ZE94-0605 in solid tumors who have exhausted all treatment options and then with expansion into two dose cohorts in select solid tumor patients.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Solid Tumor Malignancies Solid Cancer Metastatic Solid Tumor

Intervention: DRUG: ZE94-0605

Oral capsules QD

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eilean Therapeutics

Published by HT Digital Content Services with permission from Health Daily Digest....